STAT

Nerd’s notes: How we did the ClinicalTrials.gov data analysis

I have a dream that one day all public information and all software will be free, transparent, and open source, and all people will have the skills to benefit from it. We are not living in my dream world yet. But here at STAT, we’re trying to do our part to open up a little more data stored in government databases.

Our first major project after we launched was a deep data-intensive dive into clinical trials compliance. In December 2015, we published “Failure to Report,” an investigation of the reporting of human study results to ClinicalTrials.gov by government, academic, and industry scientists. We found flagrant violations of federal law and non-existent enforcement.

We didn’t just publish and hope for the best. We went back this year to check whether research organizations were doing a better job posting results. That appears to.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks